Amino Acids Clinical Disease Study Notes

Case Study: Patient Ah Sui
- Goal: A planned weight loss of $25\,kg$ within a single-month duration.
- Method: Complete cessation of dietary protein intake.
- Physiological Consequences:
  - Fatigue: Resulting from a severe calorie deficit.
  - Metabolic Impact: Significant slowing of the metabolic rate.
  - Muscle Atrophy: Gradual loss of muscle mass (muscle wasting) over time.
  - Physical Functionality: Resulted in the patient becoming progressively weaker, experiencing a measurable reduction in physical strength, and encountering marked difficulty with movement.

The Stress Response Pathway: When amino acid availability is low, the cell triggers a specific signaling cascade to adapt to the lack of nutrients.
Inhibition of Protein Synthesis: While general protein synthesis across the cell is inhibited to conserve energy, specific adaptive mechanisms are activated.
Role of $eIF2\alpha$ : The phosphorylation of the eukaryotic initiation factor $eIF2\alpha$ takes place. This phosphorylation serves two purposes:
- It inhibits global mRNA translation.
- It selectively promotes the translation of specific mRNAs, most notably those encoding for the protein $ATF4$ .
ATF4 (Activating Transcription Factor 4): This is a transcription factor that regulates the expression of genes required for survival under stress. It activates genes involved in:
- Amino Acid Biosynthesis: Increasing the internal production of essential building blocks.
- Autophagy: Initiating cellular recycling processes.
- Transporter Expression: Potentially increasing the expression of membrane transporters to scavenge any available amino acids from the extracellular environment.

Definition: Autophagy, meaning "self-eating," is a critical intracellular degradation system.
Process: The cell identifies unwanted "cargo" and sequesters it for digestion.
Cargo Types:
- Old or damaged organelles.
- Unneeded or misfolded proteins.
- Pathogenic agents (bacteria or viruses).
Outcome: The cargo is digested, and the resulting macromolecular contents (such as amino acids) are released back into the cytosol for reuse, helping the cell survive nutrient deprivation.

Protein Involved: Hemoglobin, the oxygen-transport protein found inside red blood cells ( $RBCs$ ).
Normal vs. Sickle Hemoglobin Structure:
- Normal Hemoglobin (HbA): Contains a $\beta$ chain with the sequence: $Valine-Histidine-Leucine-Threonine-Proline-Glutamic\,acid-Glutamic\,acid$ at the first seven positions.
- Sickle Cell Hemoglobin (HbS): The $\beta$ chain sequence is: $Valine-Histidine-Leucine-Threonine-Proline-Valine-Glutamic\,acid$ .
The Mutation: A single amino acid substitution occurs at the 6th position of the $\beta\,\text{subunit}$ of hemoglobin.
- Substitution: The polar amino acid Glutamate ( $Glu$ ) is replaced with the nonpolar amino acid Valine ( $Val$ ).
Consequences of the Mutation:
- Protein Aggregation: This single change creates a hydrophobic patch that causes hemoglobin molecules to clump together.
- Fiber Formation: The hemoglobin proteins aggregate into long, rigid rods or fibers.
- RBC Shape: The presence of these long rods distorts the normal disc-like shape of the red blood cell into a "sickle" or crescent shape.
- Functional Impact: Sickle-cell hemoglobin has a significantly reduced capacity to carry oxygen. Unlike normal hemoglobin molecules, which remain individual and soluble, $HbS$ molecules associate with one another, compromising cellular function.

General Definition: Phenylketonuria ( $PKU$ ) is an inherited genetic disorder characterized by the inability to properly break down the amino acid Phenylalanine ( $Phe$ ).
Dietary Sources of Phenylalanine: Phenylalanine is obtained from high-protein foods including meat, eggs, nuts, and milk, as well as certain artificial sweeteners (e.g., aspartame).
Genetic Cause: Mutations in the $PAH$ gene.
Enzymatic Deficiency: The mutation leads to a deficiency or reduced activity of the enzyme Phenylalanine hydroxylase.
- Impaired Activity: The mutated enzyme is either completely inactive or far less efficient, preventing the conversion of Phenylalanine into Tyrosine.
Pathology and Symptoms:
- Toxic Accumulation: Phenylalanine builds up to toxic levels in the blood and bodily tissues.
- Brain Damage: High levels are neurotoxic and can damage nerve cells in the brain, resulting in severe intellectual disabilities and neurological complications.
- Developmental Symptoms: Untreated $PKU$ leads to developmental delays and seizures.
- Physical Symptoms: Patients may exhibit eczema and a characteristic "musty" odor on the skin, breath, or urine.
Diagnostic Phenylalanine Levels:
- Healthy Adult Range: $35$ to $85\,\mu mol/L$ .
- Healthy Infants/Children (up to 18 years): $21$ to $137\,\mu mol/L$ .
- Untreated PKU Patients: Levels can exceed $20\,mg/dL$ (approximately $1200\,\mu mol/L$ ).

Definition: A genetic disorder involving the inability to break down the amino acid Tyrosine ( $Tyr$ ).
Pathogenesis: If untreated, Tyrosine and its metabolic byproducts accumulate in tissues and organs, causing multi-system health problems.
Chronic Tyrosinemia:
- Onset: Typically presents after 6 months of age.
- Clinical Presentation: Manifests with a gradual onset and less severe acute symptoms than the neonatal form, but carries significant long-term risks.
- Primary Symptoms:
  - Hepatomegaly (enlargement of the liver).
  - Splenomegaly (enlargement of the spleen).
  - Distended abdomen caused by fluid accumulation (ascites).
  - Failure to thrive (difficulty gaining weight).
  - Gastrointestinal distress, including vomiting and diarrhea.

Scenario: A mutation occurs in a soluble enzyme that changes an Isoleucine residue ( $Ile$ ) to Glutamic Acid ( $Glu$ ). This residue was originally located within the hydrophobic core of the protein.
Question: What is the most likely outcome for the protein?
- A) Increased stability due to new hydrogen bonds.
- B) Unchanged protein function.
- C) Denaturation or misfolding due to the introduction of a charged residue into a nonpolar environment.
- D) Conversion of the protein into a transmembrane protein.
Correct Answer: C. Introducing a charged, polar residue ( $Glu$ ) into the hydrophobic (nonpolar) core disrupts the stabilizing hydrophobic interactions, leading to protein instability and misfolding.